ArticleThoracic cancer2018

Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancer.

Xiaoyu Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.